Texas Heart Institute and Baylor St. Luke’s Medical Center Receive Houston’s First American College of Cardiology (ACC) Transcatheter Valve Certification

Experts at Texas Heart Institute and Baylor St. Luke’s Medical Center have earned a prestigious American College of Cardiology accreditation as a transcatheter aortic valve replacement (TAVR) Center of Excellence,  the first program in Houston to be recognized for this level of quality and clinical outcomes.

“This distinction underscores our commitment to excellence and the treatment of complex cardiovascular patients,”  said Texas Heart Institute’s Dr. Stephanie Coulter.

The comprehensive external review and certification process acknowledges the highest standards for training, team-based care, patient-focused decision-making, and clinical performance. The designation also requires participation in a TAVR national clinical database to achieve certification.

Centers that achieve ACC Transcatheter Valve Certification follow best practices for using evidence-based medicine to support decision-making in the care of individual patients.

“We are proud of this designation. It validates the expertise of our team, the patient care processes we have implemented, our ability to track key performance metrics, and our commitment to continuous improvement.  Our TAVR team has performed 2150 procedures in the past 9 years and is dedicated to the highest standards of quality and safety.  This focus translates to superior clinical outcomes for our patients. Dr. Juan Carlos Plana, Chief of Cardiovascular Services Baylor St. Luke’s Medical Center.


Related Research

Special Issue of the Annals of Cardiovascular Surgery with guest editor Dr. Ourania Prevenza

Annals of Cardiovascular Surgery Vol 10, No 5 (September 2021): Transcatheter Valve-in-Valve

Hemodynamic outcomes after valve-in-valve transcatheter aortic valve replacement: a single-center experience

Transcatheter valve-in-valve implantation for degenerated stentless aortic bioroots

Open transcatheter valve replacement for prosthesis-patient mismatch at redo surgical aortic valve replacement

Transcatheter pulmonary valve in failed bioprosthesis


About The Texas Heart Institute (THI)

Texas Heart Institute (THI), founded by world-renowned cardiovascular surgeon Dr. Denton A. Cooley in 1962, is a nonprofit organization dedicated to delivering the future of cardiovascular health through exceptional patient care, discovery, and a commitment to learning. Participating in research programs in cardiology, cardiovascular surgery, stem cell and gene therapy, and regenerative medicine, THI’s scientists and physicians are spearheading some of the most innovative research in the medical field. Through its translational basic and clinical research programs, Texas Heart Institute is learning more every day about the underlying causes of heart disease and the ways to better treat and even prevent it. With initiatives ranging from postdoctoral and continued medical education to public outreach and scientific publications, THI is dedicated to spreading awareness and sharing updates on ways to prevent, treat and defeat cardiovascular disease. With over 12 million visitors coming to its website from around the world every year, www.texasheart.org is just one of the ways THI is helping to educate people on the importance of heart health.